High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey

BACKGROUND: Patients with schizophrenia have an increased prevalence of metabolic disturbances compared with the general population. However, the mechanisms underlying the metabolic side effects of antipsychotics are unknown. The aim of the present study was to compare the levels of high-density lip...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Psychiatry
Autors principals: Ono, Shin, Sugai, Takuro, Suzuki, Yutaro, Yamazaki, Manabu, Shimoda, Kazutaka, Mori, Takao, Ozeki, Yuji, Matsuda, Hiroshi, Sugawara, Norio, Yasui-Furukori, Norio, Okamoto, Kurefu, Sagae, Toyoaki, Someya, Toshiyuki
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992846/
https://ncbi.nlm.nih.gov/pubmed/29879941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-018-1764-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars